When do peak withdrawal symptoms from benzodiazepines (BZDs), such as Xanax (alprazolam) and Valium (diazepam), typically occur?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peak Withdrawal Symptoms from Benzodiazepines

Peak withdrawal symptoms from benzodiazepines typically occur 1-4 days after discontinuation for short-acting benzodiazepines like alprazolam (Xanax), and may be delayed up to 5-7 days for longer-acting benzodiazepines like diazepam (Valium). 1, 2

Timing of Benzodiazepine Withdrawal

The onset and peak of benzodiazepine withdrawal symptoms depend on several factors:

  • Short-acting benzodiazepines (e.g., alprazolam):

    • Withdrawal symptoms begin within 1-2 days after discontinuation 1
    • Peak symptoms typically occur at 2-4 days 1, 3
  • Long-acting benzodiazepines (e.g., diazepam):

    • Withdrawal symptoms begin more gradually, often 2-7 days after discontinuation 3
    • Peak symptoms typically occur around 5-7 days after discontinuation 3, 1
  • Duration of withdrawal syndrome:

    • The acute withdrawal phase typically lasts 10-14 days 1
    • Some patients may experience a protracted withdrawal syndrome lasting weeks to more than 12 months 2

Factors Affecting Withdrawal Severity and Timing

Several factors influence when peak withdrawal symptoms occur:

  • Half-life of the specific benzodiazepine: Withdrawal symptoms start approximately 2-3 half-lives after the last dose 4

  • Duration of use: Longer periods of use (especially beyond 5 days of continuous administration) increase risk of withdrawal 4

  • Dosage: Higher doses lead to more severe withdrawal symptoms that may peak earlier 2, 5

  • Abrupt discontinuation vs. tapering: Abrupt discontinuation leads to earlier and more severe peak symptoms 2

  • Individual patient factors: Metabolism, age, and concurrent medications can affect timing 4

Common Withdrawal Symptoms

Benzodiazepine withdrawal manifests with various symptoms:

  • Psychological symptoms:

    • Anxiety, irritability, insomnia, restlessness 2, 1
    • Perceptual disturbances, depersonalization 2, 6
    • Panic attacks, depression 1
  • Physical symptoms:

    • Tremors, muscle pain and stiffness 2, 1
    • Sweating, tachycardia, hypertension 4, 2
    • Headache, nausea, vomiting, diarrhea 2, 1
  • Severe symptoms (less common):

    • Seizures (can occur 1-14 days after discontinuation) 7
    • Psychosis, delirium 2

Clinical Implications

Understanding the timing of peak withdrawal symptoms is crucial for management:

  • Monitoring period: Patients should be closely monitored during the expected peak withdrawal period (2-7 days depending on the specific benzodiazepine) 4, 1

  • Tapering approach: To minimize withdrawal severity, benzodiazepines should be tapered gradually rather than stopped abruptly 2, 5

  • Rebound symptoms vs. withdrawal syndrome: Distinguish between short-lived "rebound" anxiety (1-4 days) and full-blown withdrawal syndrome (10-14 days) 1

  • Risk of seizures: Withdrawal seizures can occur with both short and long-term use, but risk increases with higher doses and abrupt discontinuation 7

  • Protracted withdrawal: Some patients may experience prolonged symptoms beyond the acute phase 2

Special Considerations

  • Cross-tolerance: When switching between benzodiazepines, incomplete cross-tolerance may lead to withdrawal symptoms despite substitution 8

  • Flumazenil risk: Administration of flumazenil (benzodiazepine antagonist) can precipitate acute withdrawal symptoms in dependent patients 2

  • Concurrent substances: Withdrawal may be complicated by concurrent use of other CNS depressants, particularly alcohol or opioids 2

References

Research

The benzodiazepine withdrawal syndrome.

Addiction (Abingdon, England), 1994

Research

Withdrawal reaction after long-term therapeutic use of benzodiazepines.

The New England journal of medicine, 1986

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Benzodiazepine withdrawal syndrome: a literature review and evaluation.

The American journal of drug and alcohol abuse, 1982

Research

Benzodiazepine withdrawal seizures and management.

The Journal of the Oklahoma State Medical Association, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.